NCT05732519 · ACTIVE NOT RECRUITING

Turkish Speech Analysis Development Study

This observational study records and analyzes speech patterns in Turkish-speaking adults who have Alzheimer's disease, mild cognitive impairment, or no cognitive problems at all. Researchers want to use artificial intelligence to identify whether subtle changes in how someone speaks can help detect cognitive decline early. No phase is listed — this is a data-collection and tool-development study, not a drug or treatment trial.

You may qualify if

  • Healthy elderly volunteers will be invited to the study by advertisement, who do not have any neurological or psychiatric disorders, who do not use drugs, substances or alcohol that may affect cognitive functions, who do not have sensory defects that prevent the application of the tests, who have an SMMT score of 25 and above, who are 60 years of age and older will be included.
  • For all three groups, the criterion of having received at least 5 years of education will be sought.

You're excluded if

  • Presence of additional neurological or psychiatric disease in patient groups, and sensory deficits that prevent the application of tests.
  • Patients with advanced AD diagnosis will not be included in the study.
  • In addition, patients with a HAM-D score above 7 will be excluded from the study, since depression is thought to affect neuropsychological test performances.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2024-05-03

View full record on ClinicalTrials.gov

All APOE4 clinical trials